3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Cyclophosphamide
2
Busulfan
2
fludarabine
1
Valganciclovir
1
Transplantation
1
Therapeutics
1
Sirolimus
1
Radiotherapy
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Methotrexate
1
Melphalan
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Etoposide
1
Cyclosporine
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
tipifarnib
×
1 year
×
Clear all
No trials found.